KLOW

Kpv + Ghk Cu + Bpc 157 + Tb 500

Ask about this stack

Get a grounded answer across clinical evidence, community patterns, and risks.

Ask AI →

114

authors mention this stack

93

ran the components concurrently

KLOW (KPV + GHK-Cu + BPC-157 + TB-500) appears in 114 author journeys (93 as actual concurrent use). Common goals: unclear; weight loss, chronic inflammation, and autoimmune issues; Weight loss, muscle preservation, knee sprain recovery, and reduction of inflammation. Typical doses reported: BPC-157 500mcg, GHK-Cu 2mg, KPV 500mcg, TB-500 2mg. Reported side effects include: Occasional constipation (exacerbated by eating molasses cookies) and slight increase in heart rate

Typical doses reported

Bpc 157 500mcg
Ghk Cu 2mg
Kpv 500mcg
Tb 500 2mg

Community-reported doses are not medical guidance.

How people are running it

80

Currently running

29

Ran in the past

21

Planning to run

9

Recommended / discussed

What people use it for

unclearweight loss, chronic inflammation, and autoimmune issuesWeight loss, muscle preservation, knee sprain recovery, and reduction of inflammationpreventing loose skin during weight lossTo combat Retatrutide-induced lethargy, improve mitochondrial energy, clear brain fog, and support lifting recoveryTransition into muscle building stage, mitochondrial repair (swapping SS-31 for MOTS-C), and enhanced body recomposition

Sample reported outcomes

  • ✓ Fat loss of 0.8-1.5% per week, improvement in knee sprain recovery, and subtle improvements in skin smoothness
  • ✓ Complete resolution of brain fog, significant boost in physical stamina/motivation, and rapid recovery from intense soreness
  • ✓ Optimized fasting glucose (87 mg/dL) and clean mitochondrial energy, but heavily fatigued by HGH
  • ✓ The combination worked wonders for the author
  • ✓ Allows the author to dial up or down any compound as needed compared to running pre-made blends.
  • ✓ Significant improvements in heart palpitations and lowered heart rate, with home ECG showing zero abnormal heart rhythm activity.
  • ✓ No signs of 'Ozempic face' (facial volume loss/sagging)
  • ✓ NAD initially gave an energy boost but later caused weakness and headaches. Stalled on Tirzepatide.

Self-reported community experiences, not verified results.

Sample reported side effects

  • ⚠ Occasional constipation (exacerbated by eating molasses cookies) and slight increase in heart rate
  • ⚠ Mild, short-lived injection site sting (15 minutes) from the nightly KLOW injection
  • ⚠ Severe fatigue from HGH due to not titrating the starting dose (causing daily naps and hangover feelings); minor injection site bruising/redness from a sub-Q mishap
  • ⚠ none mentioned
  • ⚠ GHK-Cu sting (mitigated by injecting into the outer thigh)
  • ⚠ Headaches (from NAD), weakness, fever blister, nausea (from Tirzepatide)
  • ⚠ Injection fatigue ('daily injections of 5 is becoming a bit much')
  • ⚠ Theoretical concern of oversaturating tissue growth pathways (fibroblast activity, angiogenesis), though the author notes this concern is mostly anecdotal and clinical practice contradicts it.